Reliance Health and what AfCFTA means for Uganda
A clear-eyed look at whether $a checkout SDK can $digitise SME payments.
- Why it matters now for founders — and who it affects first.
- The practical move an operator can make this quarter.
- The real cost behind the Series B.
A clear-eyed look at whether $a checkout SDK can $digitise SME payments.
- Why it matters now for founders — and who it affects first.
- The practical move an operator can make this quarter.
- The real cost behind the Series B.
For anyone building in trade & industry, the useful question is where this changes your costs, distribution or competition — and how soon you act on it.
AI-generated summary. It can miss nuance — read the full story above for the complete picture.
The numbers behind Reliance Health's latest move tell a sharper story than the press release.
The team's bet is simple: digitise SME payments without burning the runway that Norrsken22 just extended.
Why it matters
Capital buys time; execution buys the market.
For most founders, the lesson isn't the raise — it's the discipline around unit economics that made it possible.
The next few months will show whether this is a durable edge or a temporary one.
What to watch next
- Whether Reliance Health can hold margins while it chases a 3x return.
- Whether the Series B buys enough runway to reach the next milestone.
- How the a checkout SDK performs outside the launch market.
The bet is placed. The market will settle it soon enough.
